Profile

Omnicell is defining and delivering the outcomes-centric innovation that is transforming medication management across all settings of care. Their purpose is to be the healthcare providers’ most trusted partner by delivering the robotics, smart devices, intelligent software, and expert services that are helping healthcare facilities worldwide to reduce costs, improve labor efficiency, establish new revenue streams, enhance supply chain control, support compliance, and move closer to the industry vision of the Autonomous Pharmacy.

Visit www.omnicell.com

Key Products

Central Pharmacy and Point of Care Automation Systems: Advanced robotics and automation designed to reduce manual tasks associated with inventory management and dispensing workflows helping to maximize inventory control, increase operational efficiency, and improve safety in medication dispensing.

Sterile Compounding Robotics: Groundbreaking technology designed to fully automate the IV compounding process for improved accuracy, enhanced patient safety, and better supply chain control for compounded sterile products.

Specialty Pharmacy: Enhance access to specialty medications and support chronic disease management through tailored services and in-house pharmacy solutions.

Key Executives

Randall Lipps, Chairman, President, CEO, and Founder

With over 30 years of experience in the healthcare industry, Randall leads Omnicell’s strategic vision and innovation in medication management.

Nchacha Etta, EVP and Chief Financial Officer

Nchacha oversees the financial operations and strategy, driving growth and efficiency within the organization.

Corey Manley, EVP and Chief Legal and Administrative Officer

Corey manages all legal and administrative functions for Omnicell, ensuring compliance and guiding the organization through regulatory challenges.

Nnamdi Njoku, EVP and Chief Operating Officer

Nnamdi leads global operations for Omnicell, driving customer experience to deliver clinical and operation outcomes, while advancing medication management through innovation.

Nish Parekh, Chief Product Officer

Nish leads product development and innovation, ensuring that Omnicell’s solutions meet the needs of healthcare providers and improve patient outcomes.

Alex Pratt, Chief Growth Officer

Alex drives Omnicell’s growth strategy, focusing on expanding market opportunities and enhancing the company’s competitive position.

Customer Insights

• Jed Tuten On Central Pharmacy Dispensing Service


• Arpit Mehta On IV Compounding Service


• You can also find Omnicell case studies here.

Investors

Omnicell, publicly traded on the NASDAQ under the ticker symbol OMCL, has successfully raised capital through multiple funding rounds. Notable investors include software and technology-focused venture capital firms such as ABS Capital, Sutter Hill Ventures, and Ascension Ventures. These strategic partnerships support Omnicell’s mission to innovate in medication management technology, driving advancements in its product offerings and strengthening its market position. Further information is available here.

Competitors

• BD Pyxis


• Swisslog


• Baxter


• Riva


• CPS/Trellis-Rx


• Capsa Healthcare

Corporate Responsibility

Omnicell’s ESG framework is fully integrated into its core strategy and is built around four pillars: Environmental, Social, Governance, and Innovation. This approach underscores the company’s commitment to making a positive impact on the planet, its employees, and the broader community.

Environmental Initiatives

Omnicell is dedicated to reducing its carbon footprint, aiming for a 1.5ºC future by 2030 with specific greenhouse gas reduction targets. Efforts include minimizing product packaging waste, improving shipping efficiency, and embedding sustainability into product development processes. Participation in the CDP Climate Change questionnaire highlights its commitment to environmental transparency.

Social Responsibility

Omnicell fosters a culture of inclusivity through programs such as Employee Impact Groups like B.R.A.I.N. and BREATHE, which promote diversity, equity, and inclusion. The company has expanded initiatives to increase gender and ethnic diversity and enhance employee engagement through inclusive training programs.

Governance

Governance efforts are strengthened by a diverse board and the ESG Ambassador Program, which ensures transparency and alignment with corporate goals.

Innovation

Omnicell’s commitment to innovation is evident in its focus on transforming healthcare through the Autonomous Pharmacy initiative, which aims to improve healthcare outcomes and efficiency.

Community Engagement

The company also prioritizes community involvement through initiatives like Omnicell Cares, which supports organ donation, volunteerism, and fundraising efforts for health causes, including the National Kidney Foundation.